Follow
Mar. 10, 2021
At the beginning of December, Britain’s health system became the first to begin vaccinating the population using Pfizer-BioNTech’s messenger RNA coronavirus vaccine.
It was the first time that messenger RNA technology, which had been used in research for about 30 years, was being used to treat the public at large. Since then, roughly 100 million people have been inoculated using mRNA vaccine produced by Pfizer-BioNTech or Moderna. The information now available about possible side effects demonstrates the vaccines are safe – even safer than many experts had anticipated.
Despite the findings, injecting unfamiliar substances into the body, particularly using new technology, has prompted a degree of public concern. Even now, these concerns have spurred on a small group of longtime anti-vaxxers who have been joined by opinion leaders in spreading false information about the COVID-19 pandemic.
Israel leads the world in vaccinations per capita, so what has the country learned? Join ISRAEL21c for a discussion with two leading experts in the field.
What the world can learn about immunity from Israel’s fast vaccine rollout
feature
What the world can learn about immunity from Israel’s fast vaccine rollout
Experts weigh in on the Pfizer-BioNTech vaccine’s effects and how Israel got to be #1 in vaccinations per capita.
By Abigail Klein Leichman
The extraordinarily fast and organized vaccination campaign in Israel is unmatched per capita anywhere in the world.
By design, this fast rollout is providing Pfizer and the rest of us with the first critical real-world data on brand-new mRNA vaccines.
This type of vaccine instructs cells to make a “spike” protein that triggers the immune system to produce antibodies against the matching spike protein on the surface of the SARS-CoV-2 coronavirus, which causes COVID-19.
What the world can learn about immunity from Israel’s vaccine rollout
Israel s extraordinary vaccination program has provided a wealth of information about the Pfizer-BioNTech vaccine and its impact.
January 27, 2021, 7:00 am
A nurse prepares a Covid-19 vaccine injection in Kiryat Ye arim outside Jerusalem. Photo by Yonatan Sindel/Flash90
More than 1.3 million Israelis have already received both doses of the Covid-19 vaccine from Pfizer-BioNTech.
By design, this fast rollout is providing Pfizer – and the rest of us – with the first critical real-world data on brand-new mRNA vaccines.
This type of vaccine instructs cells to make a “spike” protein that triggers the immune system to produce antibodies against the matching spike protein on the surface of the SARS-CoV-2 coronavirus, which causes Covid-19.